本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ABVC BioPharma, Inc.

3.35
-0.2300-6.42%
盤後3.370.0200+0.60%18:25 EDT
成交量:15.06萬
成交額:51.79萬
市值:5,444.07萬
市盈率:-14.94
高:3.60
開:3.59
低:3.35
收:3.58
資料載入中...
2021/11/15

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/11/15

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/11/15

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/11/15

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/11/15

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/10/08

重要事件披露

8-K - Current report
2021/08/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/05

重要事件披露

8-K - Current report
2021/07/29

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/29

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/29

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/28

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/21

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/21

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/08

重要事件披露

8-K/A [Amend] - Current report
2021/05/14

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/03

重要事件披露

8-K/A [Amend] - Current report
2021/04/08

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/03/16

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]